Montelukast Prescribing at KINGS PARK SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
487
Total Quantity
12.1K
NHS Cost
£583
vs National Avg
-28.9%
KINGS PARK SURGERY prescribed 487 items of Montelukast over the last 12 months at a cost of £583 to the NHS. This is 28.9% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
42
Jul 2026
38
Jul 2026
34
Jul 2026
48
Jul 2026
38
Jul 2026
35
Jul 2026
42
Jul 2026
41
Jul 2026
45
Jul 2026
44
Jul 2026
38
Jul 2026
42
Prescribing Details
| Total Items | 487 |
|---|---|
| Total Quantity | 12,124 |
| Total NHS Cost | £583 |
| Presentations | 4 different forms |
| vs National Average | -28.9% |
Montelukast Prescribing Comparison
| This practice | 487 items |
|---|---|
| National average per practice | 685 items |
| Difference | -28.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.